Disclosed is a hepatoprotective traditional Chinese medicine composition, extract and pharmaceutical use thereof. The composition comprises Morinda officinalis How, Ganoderma lucidum (Leyss. Ex Fr.) Karst., Astragalus membranaceus (Fisch) Bge. Var. monghlicus (Bge) Hsiao, Ranunculus ternatus Thunb., Sophora flavescens Alt. and Salvia miltiorrhiza Bge. The composition and extract thereof may be used for treating liver injury, hepatitis, hepatic fibrosis, hepatic cirrhosis or liver cancer, and they may also be used as a vaccine adjuvant or an immunomodulator.

Disclosed is a hepatoprotective traditional Chinese medicine composition, extract and pharmaceutical use thereof. The composition comprises Morinda officinalis How, Ganoderma lucidum (Leyss. Ex Fr.) Karst., Astragalus membranaceus (Fisch) Bge. Var. monghlicus (Bge) Hsiao, Ranunculus ternatus Thunb., Sophora flavescens Alt. and Salvia miltiorrhiza Bge. The composition and extract thereof may be used for treating liver injury, hepatitis, hepatic fibrosis, hepatic cirrhosis or liver cancer, and they may also be used as a vaccine adjuvant or an immunomodulator.

The present disclosure relates to a regimen mattress. The regimen mattress includes a memory foam, a high density (HD) foam below the memory foam, and a cover covering the memory foam and the HD foam together to form the entire mattress. The HD foam contains functional additives. The regimen mattress effectively improves the user's health condition through adding functional additives into the foam layer that is far away from the user.

The present disclosure relates to a regimen mattress. The regimen mattress includes a memory foam, a high density (HD) foam below the memory foam, and a cover covering the memory foam and the HD foam together to form the entire mattress. The HD foam contains functional additives. The regimen mattress effectively improves the user's health condition through adding functional additives into the foam layer that is far away from the user.

A composition for treating erectile dysfunction in a male mammal comprising an Orchis anatolica root bulb extract. A method of treating erectile dysfunction in a mammal comprises administering a therapeutically effective amount of Orchis anatolica root bulbs alcohol extract in a male mammal.

A composition for treating erectile dysfunction in a male mammal comprising an Orchis anatolica root bulb extract. A method of treating erectile dysfunction in a mammal comprises administering a therapeutically effective amount of Orchis anatolica root bulbs alcohol extract in a male mammal.

Embodiments herein include a composition that can include one or more saponins and one or more non-pathogenic bacterial strains. In an embodiment, a method of treating an animal to reduce the bactericidal effect of protozoa is included. The method can include administering a composition comprising saponins and administering a composition comprising at least 1×10.sup.7 colony forming units (CFU) per gram of one or more bacterial strains. The saponins can reduce a bactericidal activity of protozoa within the animal on the one or more bacterial strains. Other embodiments are also included herein.

Embodiments herein include a composition that can include one or more saponins and one or more non-pathogenic bacterial strains. In an embodiment, a method of treating an animal to reduce the bactericidal effect of protozoa is included. The method can include administering a composition comprising saponins and administering a composition comprising at least 1×10.sup.7 colony forming units (CFU) per gram of one or more bacterial strains. The saponins can reduce a bactericidal activity of protozoa within the animal on the one or more bacterial strains. Other embodiments are also included herein.

Embodiments herein include a composition that can include one or more saponins and one or more non-pathogenic bacterial strains. In an embodiment, a method of treating an animal to reduce the bactericidal effect of protozoa is included. The method can include administering a composition comprising saponins and administering a composition comprising at least 1×10.sup.7 colony forming units (CFU) per gram of one or more bacterial strains. The saponins can reduce a bactericidal activity of protozoa within the animal on the one or more bacterial strains. Other embodiments are also included herein.

Embodiments of the invention include plant stem cell products and treatment methods using the products. In some embodiments, the products may include extracts of plant stem cells, such as apple stem cells, and an aerosolizing device configured to create an aerosol from the plant stem cell products and to deliver the aerosol to the lung via inhalation. Treatment methods include aerosol inhalation of the plant stem cell products.